The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -7.43%.However, over the last six months, we can see a stronger performance of -26.04%. Over the last 30 days, the price of ORIC has leaped by -25.30%. And in the last five days, it has fallen by -20.95%.
ORIC Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $16.65 on 03/06/24 and a low of $6.33 for the same time frame on 06/27/24.
52-week price history of ORIC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. ORIC Pharmaceuticals Inc’s current trading price is -55.14% away from its 52-week high, while its distance from the 52-week low is 18.01%. The stock’s price range during this period has varied between$6.33 and $16.65. The ORIC Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.19 million for the day, a figure considerably higher than their average daily volume of 0.83 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
ORIC Pharmaceuticals Inc (ORIC) has experienced a quarterly decline of -12.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 530.57M and boasts a workforce of 115 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.42, with a change in price of -2.53. Similarly, ORIC Pharmaceuticals Inc recorded 670,391 in trading volume during the last 100 days, posting a change of -25.30%.
ORIC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ORIC stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
ORIC Stock Stochastic Average
As of today, ORIC Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 1.77%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 1.77%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 4.44% and 7.37%, respectively.
